Yang, T.-L.; Tsai, C.-H.; Su, Y.-W.; Chang, Y.-C.; Lee, F.; Huang, T.-Y.; Li, F.-Y.; Yang, P.-S.
Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer. Cancers 2025, 17, 671.
https://doi.org/10.3390/cancers17040671
AMA Style
Yang T-L, Tsai C-H, Su Y-W, Chang Y-C, Lee F, Huang T-Y, Li F-Y, Yang P-S.
Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer. Cancers. 2025; 17(4):671.
https://doi.org/10.3390/cancers17040671
Chicago/Turabian Style
Yang, Tsen-Long, Chung-Hsin Tsai, Ying-Wen Su, Yuan-Ching Chang, Fang Lee, To-Yu Huang, Fang-Yi Li, and Po-Sheng Yang.
2025. "Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer" Cancers 17, no. 4: 671.
https://doi.org/10.3390/cancers17040671
APA Style
Yang, T.-L., Tsai, C.-H., Su, Y.-W., Chang, Y.-C., Lee, F., Huang, T.-Y., Li, F.-Y., & Yang, P.-S.
(2025). Combining KPNA2 and FOXM1 Expression as Prognostic Markers and Therapeutic Targets in Hormone Receptor-Positive, HER2-Negative Breast Cancer. Cancers, 17(4), 671.
https://doi.org/10.3390/cancers17040671
